[en] Human peroxiredoxin-5 (PRDX5) is a unique redox-sensitive protein that plays a dual role in brain ischemia-reperfusion injury. While intracellular PRDX5 has been reported to act as a neuroprotective antioxidative enzyme by scavenging peroxides, once released extracellularly from necrotic brain cells, the protein aggravates neural cell death by inducing expression of proinflammatory cytokines in macrophages through activation of Toll-like receptor (TLR) 2 (TLR2) and 4 (TLR4). Although recent evidence showed that PRDX5 was able to interact directly with TLR4, little is known regarding the role of the cysteine redox state of PRDX5 on its DAMP function. To gain insights into the role of PRDX5 redox-active cysteine residues in the TLR4-dependent proinflammatory activity of the protein, we used a recombinant human PRDX5 in the disulfide (oxidized) form and a mutant version lacking the peroxidatic cysteine, as well as chemically reduced and hyperoxidized PRDX5 proteins. We first analyzed the oxidation state and oligomerization profile by Western blot, mass spectrometry, and SEC-MALS. Using ELISA, we demonstrate that the disulfide bridge between the enzymatic cysteines is required to allow improved TLR4-dependent IL-8 secretion. Moreover, single-molecule force spectroscopy experiments revealed that TLR4 alone is not sufficient to discriminate the different PRDX5 redox forms. Finally, flow cytometry binding assays show that disulfide PRDX5 has a higher propensity to bind to the surface of living TLR4-expressing cells than the mutant protein. Taken together, these results demonstrate the importance of the redox state of PRDX5 cysteine residues on TLR4-induced inflammation.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Poncin, Mégane A; Louvain Institue of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
Van Meerbeeck, Pierre; Louvain Institue of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
Simpson, Joshua D; Louvain Institue of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
Clippe, André; Louvain Institue of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
Tyckaert, François; Louvain Institue of Biomolecular Science and Technology, Université catholique de Louvain, 1348 Louvain-la-Neuve, Belgium
Funding: This research was funded by the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), grant number PDR T.0070.16 to D.A., the Research Department of the Communauté française de Belgique (Concerted Research Action); the Université catholique de Louvain (Fonds Spéciaux de Recherche). M.A.P. and D.A. are respectively FRIA researcher and Research Associate from the FNRS.This research was funded by the Fonds National de la Recherche Scientifique (F.R.S.-FNRS), grant number PDR T.0070.16 to D.A., the Research Department of the Communaut? fran?aise de Belgique (Concerted Research Action); the Universit? catholique de Louvain (Fonds Sp?ciaux de Recherche). M.A.P. and D.A. are respectively FRIA researcher and Research Associate from the FNRS.
Shau, H.; Gupta, R.K.; Golub, S.H. Identification of a Natural Killer Enhancing Factor (NKEF) from Human Erythroid Cells. Cell. Immunol. 1993, 147, 1–11. [CrossRef] [PubMed]
Zito, E.; Melo, E.P.; Yang, Y.; Wahlander, Å.; Neubert, T.A.; Ron, D. Oxidative Protein Folding by an Endoplasmic Reticulum Localized Peroxiredoxin. Mol. Cell 2010, 40, 787–797. [CrossRef] [PubMed]
Moon, J.C.; Hah, Y.-S.; Kim, W.Y.; Jung, B.G.; Jang, H.H.; Lee, J.R.; Kim, S.Y.; Lee, Y.M.; Jeon, M.G.; Kim, C.W.; et al. Oxidative Stress-Dependent Structural and Functional Switching of a Human 2-Cys Peroxiredoxin Isotype II That Enhances HeLa Cell Resistance to H2O2-Induced Cell Death. J. Biol. Chem. 2005, 280, 28775–28784. [CrossRef] [PubMed]
Choi, H.-J.; Kang, S.W.; Yang, C.-H.; Rhee, S.G.; Ryu, S.-E. Crystal Structure of a Novel Human Peroxidase Enzyme at 2.0 Å Resolution. Nat. Struct. Biol. 1998, 5, 400–406. [CrossRef]
Hirotsu, S.; Abe, Y.; Okada, K.; Nagahara, N.; Hori, H.; Nishino, T.; Hakoshima, T. Crystal Structure of a Multifunctional 2-Cys Peroxiredoxin Heme-Binding Protein 23 KDa/Proliferation-Associated Gene Product. Proc. Natl. Acad. Sci. USA 1999, 96, 12333–12338. [CrossRef]
Declercq, J.P.; Evrard, C.; Clippe, A.; Stricht, D.V.; Bernard, A.; Knoops, B. Crystal Structure of Human Peroxiredoxin 5, a Novel Type of Mammalian Peroxiredoxin at 1.5 A Resolution. J. Mol. Biol. 2001, 311, 751–759. [CrossRef]
Manevich, Y.; Feinstein, S.I.; Fisher, A.B. Activation of the Antioxidant Enzyme 1-CYS Peroxiredoxin Requires Glutathionylation Mediated by Heterodimerization with Pi GST. Proc. Natl. Acad. Sci. USA 2004, 101, 3780–3785. [CrossRef]
Seo, M.S.; Kang, S.W.; Kim, K.; Baines, I.C.; Lee, T.H.; Rhee, S.G. Identification of a New Type of Mammalian Peroxiredoxin That Forms an Intramolecular Disulfide as a Reaction Intermediate. J. Biol. Chem. 2000, 275, 20346–20354. [CrossRef]
Peshenko, I.V.; Novoselov, V.I.; Evdokimov, V.A.; Nikolaev, T.M.; Shuvaeva, V.M.; Lipkin, V.M.; Fesenko, E.E. Novel 28-KDa Secretory Protein from Rat Olfactory Epithelium. FEBS Lett. 1996, 381, 12–14. [CrossRef]
Yang, K.-S.; Kang, S.W.; Woo, H.A.; Hwang, S.C.; Chae, H.Z.; Kim, K.; Rhee, S.G. Inactivation of Human Peroxiredoxin I during Catalysis as the Result of the Oxidation of the Catalytic Site Cysteine to Cysteine-Sulfinic Acid. J. Biol. Chem. 2002, 277, 38029–38036. [CrossRef]
Woo, H.A.; Chae, H.Z.; Hwang, S.C.; Yang, K.-S.; Kang, S.W.; Kim, K.; Rhee, S.G. Reversing the Inactivation of Peroxiredoxins Caused by Cysteine Sulfinic Acid Formation. Science 2003, 300, 653–656. [CrossRef]
Lim, J.C.; Choi, H.-I.; Park, Y.S.; Nam, H.W.; Woo, H.A.; Kwon, K.-S.; Kim, Y.S.; Rhee, S.G.; Kim, K.; Chae, H.Z. Irreversible Oxidation of the Active-Site Cysteine of Peroxiredoxin to Cysteine Sulfonic Acid for Enhanced Molecular Chaperone Activity. J. Biol. Chem. 2008, 283, 28873–28880. [CrossRef]
Riddell, J.R.; Wang, X.-Y.; Minderman, H.; Gollnick, S.O. Peroxiredoxin 1 Stimulates Secretion of Pro-Inflammatory Cytokines by Binding to Toll-like Receptor 4. J. Immunol. Baltim. Md 1950 2010, 184, 1022–1030. [CrossRef]
Shichita, T.; Hasegawa, E.; Kimura, A.; Morita, R.; Sakaguchi, R.; Takada, I.; Sekiya, T.; Ooboshi, H.; Kitazono, T.; Yanagawa, T.; et al. Peroxiredoxin Family Proteins Are Key Initiators of Post-Ischemic Inflammation in the Brain. Nat. Med. 2012, 18, 911–917. [CrossRef] [PubMed]
Rafikova, O.; Lamoke, F.; Gutsaeva, D.; Jahng, W.J.; Repossi, A.; Facchiano, F.; Bartoli, M. Modulation of Toll-like Receptor 4 Signaling in Human Diabetic Retina by Peroxiredoxin 1. Invest. Ophthalmol. Vis. Sci. 2015, 56, 4288.
Lu, Y.; Zhang, X.-S.; Zhang, Z.-H.; Zhou, X.-M.; Gao, Y.-Y.; Liu, G.-J.; Wang, H.; Wu, L.-Y.; Li, W.; Hang, C.-H. Peroxiredoxin 2 Activates Microglia by Interacting with Toll-like Receptor 4 after Subarachnoid Hemorrhage. J. Neuroinflammation 2018, 15, 87. [CrossRef] [PubMed]
He, Y.; Li, S.; Tang, D.; Peng, Y.; Meng, J.; Peng, S.; Deng, Z.; Qiu, S.; Liao, X.; Chen, H.; et al. Circulating Peroxiredoxin-1 Is a Novel Damage-Associated Molecular Pattern and Aggravates Acute Liver Injury via Promoting Inflammation. Free Radic. Biol. Med. 2019, 137, 24–36. [CrossRef]
Nakamura, K.; Shichita, T. Cellular and Molecular Mechanisms of Sterile Inflammation in Ischaemic Stroke. J. Biochem. (Tokyo) 2019, 165, 459–464. [CrossRef]
Knoops, B.; Becker, S.; Poncin, M.A.; Glibert, J.; Derclaye, S.; Clippe, A.; Alsteens, D. Specific Interactions Measured by AFM on Living Cells between Peroxiredoxin-5 and TLR4: Relevance for Mechanisms of Innate Immunity. Cell Chem. Biol. 2018, 25, 550–559. [CrossRef]
Plaisant, F.; Clippe, A.; Vander Stricht, D.; Knoops, B.; Gressens, P. Recombinant Peroxiredoxin 5 Protects against Excitotoxic Brain Lesions in Newborn Mice. Free Radic. Biol. Med. 2003, 34, 862–872. [CrossRef]
Woo, H.A.; Rhee, S.G. Immunoblot Detection of Proteins That Contain Cysteine Sulfinic or Sulfonic Acids with Antibodies Specific for the Hyperoxidized Cysteine-Containing Sequence. In Methods Redox Signal; Mary Ann Liebert: New Rochelle, NY, 2010; pp. 19–23, ISBN 978-1-934857-06-8.
Goemaere, J.; Knoops, B. Peroxiredoxin Distribution in the Mouse Brain with Emphasis on Neuronal Populations Affected in Neurodegenerative Disorders. J. Comp. Neurol. 2012, 520, 258–280. [CrossRef]
Denoncin, K.; Vertommen, D.; Arts, I.S.; Goemans, C.V.; Rahuel-Clermont, S.; Messens, J.; Collet, J.-F. A New Role for Escherichia Coli DsbC Protein in Protection against Oxidative Stress. J. Biol. Chem. 2014, 289, 12356–12364. [CrossRef]
Arts, I.S.; Vertommen, D.; Baldin, F.; Laloux, G.; Collet, J.-F. Comprehensively Characterizing the Thioredoxin Interactome In Vivo Highlights the Central Role Played by This Ubiquitous Oxidoreductase in Redox Control. Mol. Cell. Proteomics MCP 2016, 15, 2125–2140. [CrossRef]
Butt, H.-J.; Jaschke, M. Calculation of Thermal Noise in Atomic Force Microscopy. Nanotechnology 1995, 6, 1. [CrossRef]
Evans, E.; Ritchie, K. Dynamic Strength of Molecular Adhesion Bonds. Biophys. J. 1997, 72, 1541–1555. [CrossRef]
Williams, P.M. Analytical Descriptions of Dynamic Force Spectroscopy: Behaviour of Multiple Connections. Anal. Chim. Acta 2003, 479, 107–115. [CrossRef]
Smeets, A.; Marchand, C.; Linard, D.; Knoops, B.; Declercq, J.-P. The Crystal Structures of Oxidized Forms of Human Peroxiredoxin 5 with an Intramolecular Disulfide Bond Confirm the Proposed Enzymatic Mechanism for Atypical 2-Cys Peroxiredoxins. Arch. Biochem. Biophys. 2008, 477, 98–104. [CrossRef]
Dubuisson, M.; Vander Stricht, D.; Clippe, A.; Etienne, F.; Nauser, T.; Kissner, R.; Koppenol, W.H.; Rees, J.-F.; Knoops, B. Human Peroxiredoxin 5 Is a Peroxynitrite Reductase. FEBS Lett. 2004, 571, 161–165. [CrossRef] [PubMed]
Banmeyer, I.; Marchand, C.; Clippe, A.; Knoops, B. Human Mitochondrial Peroxiredoxin 5 Protects from Mitochondrial DNA Damages Induced by Hydrogen Peroxide. FEBS Lett. 2005, 579, 2327–2333. [CrossRef]
Barelier, S.; Linard, D.; Pons, J.; Clippe, A.; Knoops, B.; Lancelin, J.-M.; Krimm, I. Discovery of Fragment Molecules That Bind the Human Peroxiredoxin 5 Active Site. PLOS ONE 2010, 5, e9744. [CrossRef] [PubMed]
Sardi, F.; Manta, B.; Portillo-Ledesma, S.; Knoops, B.; Comini, M.A.; Ferrer-Sueta, G. Determination of Acidity and Nucleophilicity in Thiols by Reaction with Monobromobimane and Fluorescence Detection. Anal. Biochem. 2013, 435, 74–82. [CrossRef]
Portillo-Ledesma, S.; Randall, L.M.; Parsonage, D.; Dalla Rizza, J.; Karplus, P.A.; Poole, L.B.; Denicola, A.; Ferrer-Sueta, G. Differential Kinetics of Two-Cysteine Peroxiredoxin Disulfide Formation Reveal a Novel Model for Peroxide Sensing. Biochemistry 2018, 57, 3416–3424. [CrossRef] [PubMed]
Baković, J.; Yu, B.Y.K.; Silva, D.; Chew, S.P.; Kim, S.; Ahn, S.-H.; Palmer, L.; Aloum, L.; Stanzani, G.; Malanchuk, O.; et al. A Key Metabolic Integrator, Coenzyme A, Modulates the Activity of Peroxiredoxin 5 via Covalent Modification. Mol. Cell. Biochem. 2019, 461, 91–102. [CrossRef]
Mann, M.; Meng, C.K.; Fenn, J.B. Interpreting Mass Spectra of Multiply Charged Ions. Anal. Chem. 1989, 61, 1702–1708. [CrossRef]
Reinhold, B.B.; Reinhold, V.N. Electrospray Ionization Mass Spectrometry: Deconvolution by an Entropy-Based Algorithm. J. Am. Soc. Mass Spectrom. 1992, 3, 207–215. [CrossRef]
Ferrige, A.; Seddon, M.J.; Green, B.; Jarvis, S.; Skilling, J.; Staunton, J. Disentangling Electrospray Spectra with Maximum Entropy. Rapid Commun. Mass Spectrom. 1992, 6, 707–711. [CrossRef]
Apostol, I.; Aitken, J.; Levine, J.; Lippincott, J.; Davidson, J.S.; Abbott-Brown, D. Recombinant Protein Sequences Can Trigger Methylation of N-Terminal Amino Acids in Escherichia Coli. Protein Sci. Publ. Protein Soc. 1995, 4, 2616–2618. [CrossRef]
Schwark, D.G.; Schmitt, M.A.; Fisk, J.D. Directed Evolution of the Methanosarcina Barkeri Pyrrolysyl TRNA/Aminoacyl TRNA Synthetase Pair for Rapid Evaluation of Sense Codon Reassignment Potential. Int. J. Mol. Sci. 2021, 22, E895. [CrossRef]
Barranco-Medina, S.; Lázaro, J.-J.; Dietz, K.-J. The Oligomeric Conformation of Peroxiredoxins Links Redox State to Function. FEBS Lett. 2009, 583, 1809–1816. [CrossRef]
Wood, Z.A.; Schröder, E.; Robin Harris, J.; Poole, L.B. Structure, Mechanism and Regulation of Peroxiredoxins. Trends Biochem. Sci. 2003, 28, 32–40. [CrossRef]
Knoops, B.; Goemaere, J.; Van der Eecken, V.; Declercq, J.-P. Peroxiredoxin 5: Structure, Mechanism, and Function of the Mammalian Atypical 2-Cys Peroxiredoxin. Antioxid. Redox Signal. 2011, 15, 817–829. [CrossRef] [PubMed]
Evrard, C.; Capron, A.; Marchand, C.; Clippe, A.; Wattiez, R.; Soumillion, P.; Knoops, B.; Declercq, J.-P. Crystal Structure of a Dimeric Oxidized Form of Human Peroxiredoxin 5. J. Mol. Biol. 2004, 337, 1079–1090. [CrossRef]
Wright, S.D.; Ramos, R.A.; Tobias, P.S.; Ulevitch, R.J.; Mathison, J.C. CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein. Science 1990, 249, 1431–1433. [CrossRef]
Shimazu, R.; Akashi, S.; Ogata, H.; Nagai, Y.; Fukudome, K.; Miyake, K.; Kimoto, M. MD-2, a Molecule That Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4. J. Exp. Med. 1999, 189, 1777–1782. [CrossRef] [PubMed]
Kim, S.J.; Kim, H.M. Dynamic Lipopolysaccharide Transfer Cascade to TLR4/MD2 Complex via LBP and CD14. BMB Rep. 2017, 50, 55–57. [CrossRef] [PubMed]
Yu, M.; Wang, H.; Ding, A.; Golenbock, D.T.; Latz, E.; Czura, C.J.; Fenton, M.J.; Tracey, K.J.; Yang, H. HMGB1 Signals through Toll-like Receptor (TLR) 4 and TLR2. Shock Augusta Ga 2006, 26, 174–179. [CrossRef]
Yang, H.; Hreggvidsdottir, H.S.; Palmblad, K.; Wang, H.; Ochani, M.; Li, J.; Lu, B.; Chavan, S.; Rosas-Ballina, M.; Al-Abed, Y.; et al. A Critical Cysteine Is Required for HMGB1 Binding to Toll-like Receptor 4 and Activation of Macrophage Cytokine Release. Proc. Natl. Acad. Sci. USA 2010, 107, 11942–11947. [CrossRef] [PubMed]
Venereau, E.; Casalgrandi, M.; Schiraldi, M.; Antoine, D.J.; Cattaneo, A.; De Marchis, F.; Liu, J.; Antonelli, A.; Preti, A.; Raeli, L.; et al. Mutually Exclusive Redox Forms of HMGB1 Promote Cell Recruitment or Proinflammatory Cytokine Release. J. Exp. Med. 2012, 209, 1519–1528. [CrossRef]
Liu, T.; Matsuguchi, T.; Tsuboi, N.; Yajima, T.; Yoshikai, Y. Differences in Expression of Toll-like Receptors and Their Reactivities in Dendritic Cells in BALB/c and C57BL/6 Mice. Infect. Immun. 2002, 70, 6638–6645. [CrossRef]
López, L.; Chiribao, M.L.; Girard, M.C.; Gómez, K.A.; Carasi, P.; Fernandez, M.; Hernandez, Y.; Robello, C.; Freire, T.; Piñeyro, M.D. The Cytosolic Tryparedoxin Peroxidase from Trypanosoma Cruzi Induces a Pro-Inflammatory Th1 Immune Response in a Peroxidatic Cysteine-Dependent Manner. Immunology 2021, 163, 46–59. [CrossRef] [PubMed]
Bizzarri, A.R.; Cannistraro, S. Dynamic Force Spectroscopy and Biomolecular Recognition; CRC Press: Boca Raton, FL, USA, 2012; ISBN 978-0-429-06733-4.
Alsteens, D.; Newton, R.; Schubert, R.; Martinez-Martin, D.; Delguste, M.; Roska, B.; Müller, D.J. Nanomechanical Mapping of First Binding Steps of a Virus to Animal Cells. Nat. Nanotechnol. 2017, 12, 177–183. [CrossRef]
Delguste, M.; Zeippen, C.; Machiels, B.; Mast, J.; Gillet, L.; Alsteens, D. Multivalent Binding of Herpesvirus to Living Cells Is Tightly Regulated during Infection. Sci. Adv. 2018, 4, eaat1273. [CrossRef] [PubMed]
Evans, E.A.; Calderwood, D.A. Forces and Bond Dynamics in Cell Adhesion. Science 2007, 316, 1148–1153. [CrossRef] [PubMed]
Evans, E.; Williams, P. Dynamic Force Spectroscopy. Physics of Bio-Molecules and Cells. Physique des BiomoléCules et des Cellules; Flyvbjerg, F., Jülicher, F., Ormos, P., David, F., Eds.; Springer: Berlin, Heidelberg, 2002; pp. 145–204.
